Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesDiabetes mellitusICD-10-CM e09-drug-or-chemical-induced-diabetes-mellitus
    Ask Trek AI about this page

    ICD-10-CM Code For Drug Or Chemical Induced Diabetes Mellitus: Group Overview

    The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group E09 includes diabetes mellitus due to drugs, chemicals, and toxic agents, covering conditions where medication or chemical exposure leads to hyperglycemia or insulin deficiency. These ICD-10-CM diagnosis codes are used to document instances of secondary diabetes related to specific agents, capturing disease severity, any complications, and the relationship to the causative substance. Accurate coding within the ICD-10-CM E09 group supports proper claim adjudication, complete clinical documentation, and appropriate reimbursement.

    Customize your policy alerts

    Sign up for ICD-10-CM Code For Drug Or Chemical Induced Diabetes Mellitus: Group Overview policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    ICD-10-CM E09: Drug Or Chemical Induced Diabetes Mellitus Overview

    This group includes diabetes mellitus caused by drugs, chemicals, or toxic agents that impair insulin production or action. It targets endocrine and metabolic dysfunction resulting directly from exposure to exogenous substances. Accurate coding is important for clinical records and influences reimbursement by documenting causation and treatment complexity.

    Table of contents

    Progress1 / 6

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    When to Use

    Use a code from this group when clinical documentation indicates that diabetes mellitus developed as a direct result of exposure to a specific drug, chemical, or toxic agent. Select the code that reflects the documented causative substance and any documented complications or manifestations of the diabetes.

    ICD-10-CM Codes

    86 rows

    ICD-10-CM CodeDescription
    E09.00Drug or chemical induced diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)
    E09.01Drug or chemical induced diabetes mellitus with hyperosmolarity with coma
    E09.10Drug or chemical induced diabetes mellitus with ketoacidosis without coma
    E09.11Drug or chemical induced diabetes mellitus with ketoacidosis with coma
    E09.21Drug or chemical induced diabetes mellitus with diabetic nephropathy
    E09.22Drug or chemical induced diabetes mellitus with diabetic chronic kidney disease
    E09.29Drug or chemical induced diabetes mellitus with other diabetic kidney complication
    E09.311Drug or chemical induced diabetes mellitus with unspecified diabetic retinopathy with macular edema
    E09.319Drug or chemical induced diabetes mellitus with unspecified diabetic retinopathy without macular edema
    E09.3211Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye
    E09.3212Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye
    E09.3213Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral
    E09.3219Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye
    E09.3291Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye
    E09.3292Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye
    E09.3293Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral
    E09.3299Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye
    E09.3311Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye
    E09.3312Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye
    E09.3313Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral

    Showing 1–20 of 86

    DRG Codes

    19 rows

    DRG CodeDescription
    008Simultaneous Pancreas and Kidney Transplant
    010Pancreas Transplant
    019Simultaneous Pancreas and Kidney Transplant with Hemodialysis
    073Cranial and Peripheral Nerve Disorders with MCC
    074Cranial and Peripheral Nerve Disorders without MCC
    124Other Disorders of the Eye with MCC or Thrombolytic Agent
    125Other Disorders of the Eye without MCC
    299Peripheral Vascular Disorders with MCC
    300Peripheral Vascular Disorders with CC
    301Peripheral Vascular Disorders without CC/MCC
    637Diabetes with MCC
    638Diabetes with CC
    639Diabetes without CC/MCC
    673Other Kidney and Urinary Tract Procedures with MCC
    674Other Kidney and Urinary Tract Procedures with CC
    675Other Kidney and Urinary Tract Procedures without CC/MCC
    698Other Kidney and Urinary Tract Diagnoses with MCC
    699Other Kidney and Urinary Tract Diagnoses with CC
    700Other Kidney and Urinary Tract Diagnoses without CC/MCC

    Typical Clinical Scenarios

    • An adult patient on long-term oral corticosteroids for polymyalgia rheumatica presents to primary care with persistent polyuria, polydipsia, and fasting hyperglycemia noted on labs. The clinician documents new-onset diabetes attributed to corticosteroid therapy after review of medication history and glucose patterns, and initiates diabetes management and monitoring. Typical codes: E09.9, E09.65
    • An inpatient receiving total parenteral nutrition and high-dose glucocorticoids for severe pancreatitis develops markedly elevated blood glucose requiring insulin infusion; endocrinology is consulted for acute glycemic control. Because the hyperglycemia is directly related to the parenteral nutrition and medications, a drug- or chemical-induced diabetes diagnosis is recorded to reflect the iatrogenic etiology and guide transitional care planning. Typical codes: E09.10, E09.618
    • A patient with chemotherapy for hematologic malignancy develops chronic hyperglycemia and later presents with nonproliferative diabetic retinopathy detected on ophthalmology exam; the treating team attributes the diabetes to prolonged exposure to alkylating agents and corticosteroids. The diabetes is coded as drug- or chemical-induced with specification of the ophthalmic microvascular complication to capture the complication of the secondary diabetes. Typical codes: E09.3211, E09.3411

    Related Codes

    E08-DIABETES-MELLITUS-DUE-TO-UNDERLYING-CONDITION

    ICD-10-CM Code For Diabetes Mellitus Due To Underlying Condition: Group Overview

    E10-TYPE-1-DIABETES-MELLITUS

    ICD-10-CM Code For Type 1 Diabetes Mellitus: Group Overview

    E11-TYPE-2-DIABETES-MELLITUS

    ICD-10-CM Code For Type 2 Diabetes Mellitus: Group Overview

    E13-OTHER-SPECIFIED-DIABETES-MELLITUS

    ICD-10-CM Code For Other Specified Diabetes Mellitus: Group Overview

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.